Clinical Professor of Dermatology and Pathology
University of Texas Southwestern Medical Center
Dallas, TX
Theodore Rosen, MD
Faculty
Professor of Dermatology
Baylor College of Medicine
Chief of the VA Dermatology Service
VA Medical Center
Houston, TX
Upon completion of this activity, the participant should be better able to:
Discuss how to integrate two new agents into the therapeutic regimen for impetigo
Recognize the distinction between diagnostic and prognostic genetic testing and limitations of each and when to order
Examine the concepts of genetic testing in melanoma and when to order
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and Dermatology University. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Almirall.
CONFLICTS OF INTEREST/DISCLOSURES
Clay Cockerell, MD has disclosed that he has no relevant financial relationships specific to the subject matter within the past 12 months.
Theodore Rosen, MD
Consultant: Bausch Health (Ortho Derm)
Advisory Board: Digitech, Foamix, Leo, Menlo
Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.